Intervention

Pravastatin

ClinicalTrials.gov intervention label

Clinical trials25

Recruiting1

Common conditions25

Lead sponsors shown15

Clinical trials

25 shown

Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of LifeNCT04356209 · 2020-01-31

Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy ParticipantsNCT04608344 · 2020-11-04

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialNCT04190433 · 2020-09-01

Pravastatin to Prevent PreeclampsiaNCT03944512 · 2019-07-17

Indonesia Pravastatin to Prevent Preeclampsia StudyNCT03648970 · 2018-03-01

Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and PravastatinNCT03131973 · 2017-05-13

High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIVNCT02841774 · 2016-11-01

An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 DiabetesNCT05107063 · 2016-01-20

Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing PotentialNCT02621957 · 2015-12-01

Effect of Pravastatin in the Subjects With Prediabetes or Early DiabetesNCT02754739 · 2014-04-15

Pravastatin for Prevention of PreeclampsiaNCT01717586 · 2012-08-01

High Potency Statins and the Risk of DiabetesNCT02518503 · 2012-07-01

The Statins on Glucose Homeostasis in Subjects With Impaired Fasting GlucoseNCT01816997 · 2012-01-01

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected SubjectsNCT01301066 · 2010-12-01

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event AssessmentsNCT01173939 · 2010-07-01

Effects of Pravastatin on Cholesterol, Inflammation and Cognition in SchizophreniaNCT01082588 · 2010-06-01

Cardiovascular Prevention for Persons With HIVNCT00982189 · 2009-09-01

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)NCT00665717 · 2008-05-01

Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and PravastatinNCT00630734 · 2008-02-01

Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)NCT00117494 · 2005-10-01

Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple SclerosisNCT00200655 · 2004-12-01

Effect of Statins on Oxidative Stress and Endothelial Progenitor CellsNCT00166036 · 2004-09-01

Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With PravastatinNCT00177580 · 2003-07-01

Endothelial Dysfunction as a Risk Factor in HIV StudyNCT00039663 · 2002-05-01

Pravastatin for Hyperlipidaemia in HIV.NCT00227500 · 2001-07-01

Common conditions

Leading sponsors

Bristol-Myers Squibb1 Canadian Network for Observational Drug Effect Studies, CNODES1 Daiichi Sankyo1 Emory University1 French National Agency for Research on AIDS and Viral Hepatitis1 Genentech, Inc.1 Gilead Sciences1 Hennepin Healthcare Research Institute1 Institut du Cancer de Montpellier - Val d'Aurelle1 Kirby Institute1 Kowa Research Institute, Inc.1 Massachusetts General Hospital1 Matthew Feinstein1 Mayo Clinic1 Nantes University Hospital1

Trial status mix

COMPLETED19

TERMINATED2

UNKNOWN2

RECRUITING1

WITHDRAWN1

Phase mix

PHASE48

PHASE16

PHASE25

NA2

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.